Pancreatic Cancer Research

ResearcherUniversity of Colorado Cancer CenterNo recent work listed

Stephen Leong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8838-8542; OpenAlex author ID A5103144296. Sources: ClinicalTrials.gov.

Their work

Papers
2
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2007: 1 trial · 2008: none · 2009: none · 2010: none · 2011: none · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 2

  1. Outcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort study. Co-author DOI 10.1093/bjs/znab092↗
  2. Patterns of Care for Locally Advanced Pancreatic Adenocarcinoma Using the National Cancer Database. Co-author DOI 10.1097/mpa.0000000000000876↗

Trials 1

  1. Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors Principal investigator NCT00551096↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Karyn A. Goodman · 2 shared papers, 2017–2021 · strength 0.16
  2. Christopher Hanyoung Lieu · 2 shared papers, 2017–2021 · strength 0.16
  3. Sarah Lindsey Davis · 2 shared papers, 2017–2021 · strength 0.16
  4. Wells A. Messersmith · 2 shared papers, 2017–2021 · strength 0.16
  5. Alexis Diane Leal · 1 shared paper, 2021 · strength 0.10
  6. Ana Gleisner · 1 shared paper, 2021 · strength 0.10
  7. Atsushi Oba · 1 shared paper, 2021 · strength 0.10
  8. Yuki Fujiwara · 1 shared paper, 2021 · strength 0.10
  9. Sana D. Karam · 1 shared paper, 2021 · strength 0.10
  10. Marco Del Chiaro · 1 shared paper, 2021 · strength 0.10
  11. Richard David Schulick · 1 shared paper, 2021 · strength 0.10
  12. Bernard L. Jones · 1 shared paper, 2017 · strength 0.06
  13. Arya Amini · 1 shared paper, 2017 · strength 0.06
  14. Colin D. Weekes · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.